Android app Apple app link

Japan Approves SIGA Technologies Antiviral As First For Smallpox, Mpox

By Yahoo! Finance   |   11 months ago
Japan Approves SIGA Technologies Antiviral As First For Smallpox, Mpox

Japan approved SIGA Technologies' antiviral treatment TEPOXX for smallpox, mpox, and cowpox, the first orthopoxvirus therapy in Japan. Studies showed efficacy in reducing mortality and viral load. The drug inhibits VP37 protein, slowing virus spread.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.